Micronuclear ecDNA constrains tumor cell fitness and is associated with favorable patient survival.

Micronuclear ecDNA formation under replication stress reduces tumor cell fitness and is linked to improved survival in MYCN-amplified neuroblastoma patients.

• Why it matters: Understanding how ecDNA contributes to tumor heterogeneity and instability is crucial for developing targeted therapies, especially since ecDNA-driven tumors often have poor prognoses.
• What they did: The study analyzed ecDNA damage, segregation, and micronuclei formation in cancer cells, using single-MN sequencing and patient data from MYCN-amplified neuroblastoma, focusing on ecDNA + MNs.
• The result: Higher ecDNA + MN frequencies correlate with impaired cell proliferation and better overall survival, suggesting ecDNA mis-segregation limits tumor fitness and may serve as a therapeutic vulnerability.